Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study.
Fonseca E, Grau JJ, Sastre J, García-Gómez JM, Rueda A, Pastor M, Lara MA, Navalón M, Berrocal A, Tisaire JL, Cruz JJ. Fonseca E, et al. Among authors: berrocal a. Eur J Cancer. 2005 Jun;41(9):1254-60. doi: 10.1016/j.ejca.2005.02.019. Eur J Cancer. 2005. PMID: 15908196 Clinical Trial.
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.
Hitt R, Grau JJ, López-Pousa A, Berrocal A, García-Girón C, Irigoyen A, Sastre J, Martínez-Trufero J, Brandariz Castelo JA, Verger E, Cruz-Hernández JJ; Spanish Head and Neck Cancer Cooperative Group (TTCC). Hitt R, et al. Among authors: berrocal a. Ann Oncol. 2014 Jan;25(1):216-25. doi: 10.1093/annonc/mdt461. Epub 2013 Nov 19. Ann Oncol. 2014. PMID: 24256848 Free article. Clinical Trial.
Chemotherapy-induced neutropenia does not correlate with DNA repair gene polymorphisms and treatment efficacy in advanced non-small-cell lung cancer patients.
Iranzo V, Sirera R, Bremnes RM, Blasco A, Jantus-Lewintre E, Tarón M, Berrocal A, Blasco S, Caballero C, Del Pozo N, Rosell R, Camps C. Iranzo V, et al. Among authors: berrocal a. Clin Lung Cancer. 2011 Jul;12(4):224-30. doi: 10.1016/j.cllc.2011.03.023. Epub 2011 Apr 24. Clin Lung Cancer. 2011. PMID: 21726821
Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
González Barón M, Artal A, Garrido P, García Girón C, Ordóñez A, Feliu J, Berrocal A, Barón JM. González Barón M, et al. Among authors: berrocal a. Am J Clin Oncol. 1993 Aug;16(4):310-4. doi: 10.1097/00000421-199308000-00006. Am J Clin Oncol. 1993. PMID: 8392287 Clinical Trial.
Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
Grünwald V, Chirovsky D, Cheung WY, Bertolini F, Ahn MJ, Yang MH, Castro G, Berrocal A, Sjoquist K, Kuyas H, Auclair V, Guillaume X, Joo S, Shah R, Harrington K; GLANCE H&N STUDY Investigators. Grünwald V, et al. Among authors: berrocal a. Oral Oncol. 2020 Mar;102:104526. doi: 10.1016/j.oraloncology.2019.104526. Epub 2020 Jan 21. Oral Oncol. 2020. PMID: 31978755 Free article.
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain.
Feliu J, González Barón M, García Girón C, Espinosa E, Vicent JM, Gómez Navarro J, Berrocal A, Ordóñez A, Vilches Y, de Castro J, Díaz J. Feliu J, et al. Among authors: berrocal a. Am J Clin Oncol. 1996 Dec;19(6):577-80. doi: 10.1097/00000421-199612000-00009. Am J Clin Oncol. 1996. PMID: 8931675 Clinical Trial.
490 results